TMCnet News

Rigrodsky & Long, P.A. Announces Investigation Of Intermec, Inc. Buyout
[December 10, 2012]

Rigrodsky & Long, P.A. Announces Investigation Of Intermec, Inc. Buyout


WILMINGTON, Del. --(Business Wire)--

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Intermec (News - Alert), Inc. ("Intermec" or the "Company") (NYSE: IN) regarding possible breaches of fiduciary duties and other violations of law related to the Company's entry into an agreement to be acquired by Honeywell (News - Alert) International Inc. ("Honeywell") (NYSE: HON) in a transaction valued at approximately $600 million.

Click here to learn more: http://www.rigrodskylong.com/investigations/intermec-inc-in.



Under the terms of the proposal, public shareholders of Intermec will receive $10.00 per share in cash for each share of Intermec they own.

The investigation concerns whether Intermec's board of directors failed to adequately shop the Company and obtain the best possible value for Intermec's shareholders before entering into an agreement with Honeywell.


If you own the common stock of Intermec and purchased your shares before December 10, 2012, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Peter Allocco at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530 toll free at (888) 969-4242, by e-mail to [email protected], or at: http://www.rigrodskylong.com/investigations/intermec-inc-in.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.


[ Back To TMCnet.com's Homepage ]